Agency Information Collection Activities: Proposed Collection; Comment Request, 104545-104546 [2024-30620]

Download as PDF Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices program, you may contact Anne Pesto, Senior Advisor, Marketplace Eligibility and Enrollment Group, Center for Consumer Information and Insurance Oversight, Centers for Medicare & Medicaid Services, at 667–290–9486, by email at anne.pesto@cms.hhs.gov, or by mail at 7500 Security Blvd., Baltimore, MD 21244. SUPPLEMENTARY INFORMATION: The Privacy Act of 1974, as amended (5 U.S.C. 552a) provides certain protections for individuals applying for and receiving Federal benefits. The law governs the use of computer matching by Federal agencies when records in a system of records (meaning, Federal agency records about individuals retrieved by name or other personal identifier) are matched with records of other Federal or non-Federal agencies. The Privacy Act requires agencies involved in a matching program to: 1. Enter into a written agreement, which must be prepared in accordance with the Privacy Act, approved by the Data Integrity Board of each source and recipient Federal agency, provided to Congress and the Office of Management and Budget (OMB), and made available to the public, as required by 5 U.S.C. 552a(o), (u)(3)(A), and (u)(4). 2. Notify the individuals whose information will be used in the matching program that the information they provide is subject to verification through matching, as required by 5 U.S.C. 552a(o)(1)(D). 3. Verify match findings before suspending, terminating, reducing, or making a final denial of an individual’s benefits or payments or taking other adverse action against the individual, as required by 5 U.S.C. 552a(p). 4. Report the matching program to Congress and the OMB, in advance and annually, as required by 5 U.S.C. 552a(o) (2)(A)(i), (r), and (u)(3)(D). 5. Publish advance notice of the matching program in the Federal Register as required by 5 U.S.C. 552a(e)(12). This matching program meets these requirements. khammond on DSK9W7S144PROD with NOTICES Barbara Demopulos, Privacy Act Officer, Division of Security, Privacy Policy and Governance, Office of Information Technology, Centers for Medicare & Medicaid Services. Participating Agencies The Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS) is the recipient agency, and the Department of the Treasury (Treasury), Internal Revenue Service (IRS) is the source agency. VerDate Sep<11>2014 17:03 Dec 20, 2024 Jkt 265001 Authority for Conducting the Matching Program The authority for the matching program is 42 U.S.C. 18001, et seq. Purpose(s) The purpose of the matching program is to provide CMS with IRS Federal tax information which CMS and State-based administering entities (AEs) will use to verify household income and family size for applicants and enrollees receiving eligibility determinations and redeterminations for benefits under the Patient Protection and Affordable Care Act (PPACA), including: enrollment in a Qualified Health Plan (QHP) or a State’s Basic Health Plan (BHP) through the federally-facilitated Exchange (FFE) or a State-based Exchange (SBE); advance payments of the premium tax credit (APTC); a cost sharing reduction (CSR); enrollment in Medicaid and the Children’s Health Insurance Program (CHIP); and certain certificates of exemption. Categories of Individuals Categories of Records The categories of records used in the matching program are identity information and Federal tax information (specifically, household income and family size information). To request Federal tax information from IRS, CMS will provide IRS with the relevant taxpayer’s name, social security number (SSN), and relationship to the applicant(s) or enrollee(s) (i.e., primary, spouse, or dependent). When IRS is able to match the SSN and name provided by CMS and Federal tax information is available, IRS will disclose to CMS the following items of Federal tax information with respect to that taxpayer: 1. SSN; 2. family size; 3. filing status; 4. modified adjusted gross income (MAGI); 5. taxable Social Security benefits; 6. adjusted gross income (AGI) for adjusted tax returns; 7. taxable year with respect to which the preceding information relates or, if Frm 00035 Fmt 4703 Sfmt 4703 applicable, the fact that such information is not available; and 8. any other specified item of Federal tax information (FTI) authorized pursuant to 26 U.S.C. 6103(1)(21) and its implementing regulations. System(s) of Records The records used in this matching program will be disclosed from the following systems of records, as authorized by routine uses published in the System of Records Notices (SORNs) cited below: A. System of Records Maintained by CMS • CMS Health Insurance Exchanges System (HIX), CMS System No. 09–70– 0560, last published in full at 78 FR 63211 (Oct. 23, 2013), as amended at 83 FR 6591 (Feb. 14, 2018). B. System of Records Maintained by IRS • FTI Treasury/IRS 24.030, published at 80 FR 54064 (Sept. 8, 2015). [FR Doc. 2024–30522 Filed 12–20–24; 8:45 am] BILLING CODE 4120–03–P The individuals whose information will be used in the matching program are consumers (applicants and enrollees) who receive the eligibility determinations and redeterminations described in the preceding Purpose(s) section (in particular, taxpayers whose Federal tax information is requested from IRS to verify an applicant’s or enrollee’s household income and family size). PO 00000 104545 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10630 and CMS–10798] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and SUMMARY: E:\FR\FM\23DEN1.SGM 23DEN1 104546 Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by February 21, 2025. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: lll, Room C4–26– 05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: khammond on DSK9W7S144PROD with NOTICES Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10630 The PACE Organization (PO) Monitoring and Audit Process CMS–10798 Application for Part B Immunosuppressive Drug Coverage (Part B–ID) Under the PRA (44 U.S.C. 3501– 3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is VerDate Sep<11>2014 17:03 Dec 20, 2024 Jkt 265001 defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collections 1. Type of Information Collection Request: Revision of a currently approved information collection; Title of Information Collection: The PACE Organization (PO) Monitoring and Audit Process; Use: Sections 1894(e)(4) and 1934(e)(4) of the Act and the implementing regulations at 42 CFR 460.190 and 460.192 mandate that CMS, in conjunction with the SAA, audit POs annually for the first 3 years (during the trial period), and then on an ongoing basis following the trial period. The information gathered during this audit will be used by the Medicare Parts C and D Oversight and Enforcement Group (MOEG) within the Center for Medicare (CM), as well as the SAA, to assess POs’ compliance with PACE program requirements. If outliers or other data anomalies are detected, other offices within CMS will work in collaboration with MOEG for follow-up and resolution. Additionally, POs will receive the audit results and will be required to implement corrective action to correct any identified deficiencies. Information collected from the POs for use in the audit is obtained electronically through the Health Plan Management System (HPMS). HPMS is a system that was developed and is maintained by CMS and is used to securely transmit information between CMS and POs. All POs have access to HPMS, and users create and maintain a secure user id and password that is used each time HPMS is accessed. Form Number: CMS–10630 (OMB control number: 0938–1327); Frequency: Annually; Affected Public: Private Sector, State, Local, or Tribal Governments, Business or other forprofits, Not-for-profits institutions; Number of Respondents: 40; Total Annual Responses: 43; Total Annual Hours: 31,200. (For policy questions PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 regarding this collection contact Katrina Hoadley at 410–786–8480 or katrina.hoadley@cms.hhs.gov). 2. Type of Information Collection Request: Revision of a currently approved information collection; Title: Application for Part B Immunosuppressive Drug Coverage (Part B–ID); Use: Sections 226A, 1836(b) and 1837(n) of the Act provide the statutory authority for this new, limited Medicare entitlement program. It is stated in § 407.1(a)(6) that, sections 1836(b) and 1837(n) of the Act provide for coverage of immunosuppressive drugs as described in section 1861(s)(2)(J) of the Act under Part B beginning on or after January 1, 2023, for eligible individuals whose benefits under Medicare Part A and eligibility to enroll in Part B on the basis of ESRD would otherwise end with the 36th month after the month in which the individual receives a kidney transplant by reason of section 226A(b)(2) of the Act. The CMS–10798 provides the necessary information to determine eligibility and to process the beneficiary’s request for enrollment for in Part B–ID coverage. This form is only used for enrollment by beneficiaries whose Medicare entitlement based on ESRD would otherwise end after a successful kidney transplant to continue enrollment under Medicare Part B only for the coverage of immunosuppressive drugs who already have Part A, but not Part B. Form CMS–10798 is completed by the individual or is completed by an SSA representative using information provided by the Medicare enrollee during a telephone interview. The form is owned by CMS, but not completed by CMS staff. SSA processes Medicare enrollments on behalf of CMS. Form Number: CMS–10798 (OMB control number: 0938–1428); Frequency: Once; Affected Public: Individuals and Households, State, Local, or Tribal Governments; Number of Respondents: 1,019; Total Annual Responses: 1,019; Total Annual Hours: 173. (For policy questions regarding this collection contact Tyrissa Woods at 410–786–0286 or Tyrissa.woods@cms.hhs.gov.) William N. Parham, III, Director, Division of Information Collections and Regulatory Impacts, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2024–30620 Filed 12–20–24; 8:45 am] BILLING CODE 4120–01–P E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104545-104546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30620]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifiers: CMS-10630 and CMS-10798]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (PRA), Federal agencies are required to publish notice in 
the Federal Register concerning each proposed collection of information 
(including each proposed extension or reinstatement of an existing 
collection of information) and to allow 60 days for public comment on 
the proposed action. Interested persons are invited to send comments 
regarding our burden estimates or any other aspect of this collection 
of information, including the necessity and utility of the proposed 
information collection for the proper performance of the agency's 
functions, the accuracy of the estimated burden, ways to enhance the 
quality, utility, and

[[Page 104546]]

clarity of the information to be collected, and the use of automated 
collection techniques or other forms of information technology to 
minimize the information collection burden.

DATES: Comments must be received by February 21, 2025.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted in any one of the following ways:
    1. Electronically. You may send your comments electronically to 
https://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number: ___, Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION:

Contents

    This notice sets out a summary of the use and burden associated 
with the following information collections. More detailed information 
can be found in each collection's supporting statement and associated 
materials (see ADDRESSES).

CMS-10630 The PACE Organization (PO) Monitoring and Audit Process
CMS-10798 Application for Part B Immunosuppressive Drug Coverage (Part 
B-ID)

    Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain 
approval from the Office of Management and Budget (OMB) for each 
collection of information they conduct or sponsor. The term 
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies 
to publish a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each proposed extension 
or reinstatement of an existing collection of information, before 
submitting the collection to OMB for approval. To comply with this 
requirement, CMS is publishing this notice.

Information Collections

    1. Type of Information Collection Request: Revision of a currently 
approved information collection; Title of Information Collection: The 
PACE Organization (PO) Monitoring and Audit Process; Use: Sections 
1894(e)(4) and 1934(e)(4) of the Act and the implementing regulations 
at 42 CFR 460.190 and 460.192 mandate that CMS, in conjunction with the 
SAA, audit POs annually for the first 3 years (during the trial 
period), and then on an ongoing basis following the trial period. The 
information gathered during this audit will be used by the Medicare 
Parts C and D Oversight and Enforcement Group (MOEG) within the Center 
for Medicare (CM), as well as the SAA, to assess POs' compliance with 
PACE program requirements. If outliers or other data anomalies are 
detected, other offices within CMS will work in collaboration with MOEG 
for follow-up and resolution. Additionally, POs will receive the audit 
results and will be required to implement corrective action to correct 
any identified deficiencies.
    Information collected from the POs for use in the audit is obtained 
electronically through the Health Plan Management System (HPMS). HPMS 
is a system that was developed and is maintained by CMS and is used to 
securely transmit information between CMS and POs. All POs have access 
to HPMS, and users create and maintain a secure user id and password 
that is used each time HPMS is accessed. Form Number: CMS-10630 (OMB 
control number: 0938-1327); Frequency: Annually; Affected Public: 
Private Sector, State, Local, or Tribal Governments, Business or other 
for-profits, Not-for-profits institutions; Number of Respondents: 40; 
Total Annual Responses: 43; Total Annual Hours: 31,200. (For policy 
questions regarding this collection contact Katrina Hoadley at 410-786-
8480 or [email protected]).
    2. Type of Information Collection Request: Revision of a currently 
approved information collection; Title: Application for Part B 
Immunosuppressive Drug Coverage (Part B-ID); Use: Sections 226A, 
1836(b) and 1837(n) of the Act provide the statutory authority for this 
new, limited Medicare entitlement program. It is stated in Sec.  
407.1(a)(6) that, sections 1836(b) and 1837(n) of the Act provide for 
coverage of immunosuppressive drugs as described in section 
1861(s)(2)(J) of the Act under Part B beginning on or after January 1, 
2023, for eligible individuals whose benefits under Medicare Part A and 
eligibility to enroll in Part B on the basis of ESRD would otherwise 
end with the 36th month after the month in which the individual 
receives a kidney transplant by reason of section 226A(b)(2) of the 
Act.
    The CMS-10798 provides the necessary information to determine 
eligibility and to process the beneficiary's request for enrollment for 
in Part B-ID coverage. This form is only used for enrollment by 
beneficiaries whose Medicare entitlement based on ESRD would otherwise 
end after a successful kidney transplant to continue enrollment under 
Medicare Part B only for the coverage of immunosuppressive drugs who 
already have Part A, but not Part B.
    Form CMS-10798 is completed by the individual or is completed by an 
SSA representative using information provided by the Medicare enrollee 
during a telephone interview. The form is owned by CMS, but not 
completed by CMS staff. SSA processes Medicare enrollments on behalf of 
CMS. Form Number: CMS-10798 (OMB control number: 0938-1428); Frequency: 
Once; Affected Public: Individuals and Households, State, Local, or 
Tribal Governments; Number of Respondents: 1,019; Total Annual 
Responses: 1,019; Total Annual Hours: 173. (For policy questions 
regarding this collection contact Tyrissa Woods at 410-786-0286 or 
[email protected].)

William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts, 
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-30620 Filed 12-20-24; 8:45 am]
BILLING CODE 4120-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.